Affordable Access

Access to the full text

Explaining performing R&D through alliances: Implications for the business model of Italian dedicated biotech firms

Authors
  • Sorrentino, Fabio1
  • Garraffo, Francesco2
  • 1 Second University of Naples, Department of Strategy and Quantitative Methods, Corso Gran Priorato di Malta 1, Capua, 81043, Italy , Capua (Italy)
  • 2 University of Catania, Department of Business Economics and Management, Corso Italia, 55, Catania, 95129, Italy , Catania (Italy)
Type
Published Article
Journal
Journal of Management & Governance
Publisher
Springer US
Publication Date
Aug 06, 2010
Volume
16
Issue
3
Pages
449–475
Identifiers
DOI: 10.1007/s10997-010-9159-9
Source
Springer Nature
Keywords
License
Yellow

Abstract

In recent years management scholars and practitioners have been interested in Research and Development (R&D) partnering, especially in high-tech industries. While the motivations of research partnership formation have been widely explored in literature, little attempt has been undertaken to examine the effects of research partnerships on R&D productivity and the implications for business models of the new ventures. In this paper we try to shed some light on the business models of the young ventures involved in R&D partnerships and their effect on R&D productivity. Our hypotheses are that experience in previous alliances, repeated partnerships and tight relationships have positive effects on R&D productivity while rigid governance structures and public R&D subsidies have negative effects on such productivity. We discuss how these aspects affect the business models of biotech firms. We test our hypotheses on a sample of 55 Italian DBFs (Dedicated Biotech Firms). Results support our hypotheses. Managerial implications and further issues for future research are discussed.

Report this publication

Statistics

Seen <100 times